USFDA completes GMP inspection of Dr Reddy’s Hyderabad API manufacturing facility
The inspection closed with zero observations
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s
Dr Reddy’s ropes in Sonu Sood as brand ambassador for Rebalanz VITORS
Rebalanz VITORS is a ready-to-serve fruit beverage with essential electrolytes and minerals to help replenish essential salts in…
Express Pharma-Nutrify Today Boardroom series to be launched this February
The Express Pharma- Nutrify Today Boardroom series, to be held in various cities of India through 2023, is an endeavour to…
Dr Reddy’s Lab Q3 results: Consolidated net profit up 77 per cent at Rs 1,247 crore
The drug firm had reported a net profit of Rs 706 crore in the October-December period of the previous fiscal.
Dr Reddy’s completes clinical studies of rituximab biosimilar for filing in US and Europe
Dr Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets
Dr Reddy’s reduces price of cardiovascular drug Cidmus
Following price reduction, Cidmus will be priced at Rs 29 for 50 mg, Rs 49 for 100 mg and Rs
79 for 200 mg per tablet
Dr Reddy’s launches in-house palbociclib to widen access to breast cancer drug
Dr Reddy's is among select companies to have conducted bioequivalence study, and has already received tentative approval from the…
Dr Reddy’s completes phase-I study of proposed biosimilar of Tocilizumab
Tocilizumab is an anti-rheumatic agent used in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis…
Dr Reddy’s and Sun Pharma recall products in US due to manufacturing issues
While Dr Reddy's Laboratories is recalling a drug used to treat sneezing, runny or stuffy nose, Sun Pharma is recalling cartons of…
‘Science 2022 Top Employer List’ recognises two Indian pharma companies
Biocon and Dr Reddy's have been recognised by 'Science' magazine in the top 10 and top 20 employers list, respectively